Use of (R)-verapamil for the treatment of abnormal increases in gastrointestinal motility

Details for Australian Patent Application No. 2002351118 (hide)

International Classifications

Event Publications

20 March 2003 Complete Application Filed

Priority application(s): 10/256,261 27.09.02 US

3 June 2004 Application Open to Public Inspection

Published as AU-B-2002351118

9 June 2005 Assignment before Grant

Kelly, John; Devane, John The application has been assigned to AGI Therapeutics Limited 2003

8 June 2006 Change of Name(s) of Applicant(s), Section 104

AGI Therapeutics Limited The name of the applicant has been changed to AGI Therapeutics Research Limited 2003

3 August 2006 Amendment Made

The nature of the amendment is: Add co-inventors Dinan, Timothy and Keeling, P.W. Napoleon 2003

12 March 2009 Application Accepted

Published as AU-B-2002351118

9 July 2009 Standard Patent Sealed

10 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.